佰泽医疗发布中期业绩 股东应占亏损2762万元 同比扩大139.18%
BAYZED HEALTHBAYZED HEALTH(HK:02609) Zhi Tong Cai Jing·2025-08-26 14:39

Core Viewpoint - Baize Medical (02609) reported a mid-term performance for the six months ending June 30, 2025, showing a slight revenue increase but a significant loss for shareholders [1] Financial Performance - Revenue reached 575 million RMB, reflecting a year-on-year increase of 0.66% [1] - Shareholder's loss amounted to 27.62 million RMB, which represents a year-on-year increase of 139.18% [1] - Basic loss per share was reported at 0.02 RMB [1]